- Home
- SFST vs GNFT Comparison
SFST vs GNFT Comparison
Compare SFST & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- GNFT
- Stock Information
- Founded
- SFST 1999
- GNFT 1999
- Country
- SFST United States
- GNFT France
- Employees
- SFST N/A
- GNFT N/A
- Industry
- SFST Major Banks
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SFST Finance
- GNFT Health Care
- Exchange
- SFST Nasdaq
- GNFT Nasdaq
- Market Cap
- SFST 285.9M
- GNFT 186.3M
- IPO Year
- SFST 1999
- GNFT 2019
- Fundamental
- Price
- SFST $39.61
- GNFT $3.93
- Analyst Decision
- SFST Buy
- GNFT Strong Buy
- Analyst Count
- SFST 1
- GNFT 1
- Target Price
- SFST $43.00
- GNFT $13.00
- AVG Volume (30 Days)
- SFST 20.0K
- GNFT 3.9K
- Earning Date
- SFST 07-29-2025
- GNFT 09-18-2025
- Dividend Yield
- SFST N/A
- GNFT N/A
- EPS Growth
- SFST 37.29
- GNFT N/A
- EPS
- SFST 2.25
- GNFT 0.03
- Revenue
- SFST $97,501,000.00
- GNFT $73,187,701.00
- Revenue This Year
- SFST $6.08
- GNFT $15.98
- Revenue Next Year
- SFST $13.23
- GNFT N/A
- P/E Ratio
- SFST $17.65
- GNFT $125.66
- Revenue Growth
- SFST 11.95
- GNFT 105.01
- 52 Week Low
- SFST $29.14
- GNFT $2.55
- 52 Week High
- SFST $45.91
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SFST 59.23
- GNFT 52.26
- Support Level
- SFST $38.46
- GNFT $3.72
- Resistance Level
- SFST $39.86
- GNFT $3.96
- Average True Range (ATR)
- SFST 0.80
- GNFT 0.14
- MACD
- SFST -0.04
- GNFT 0.03
- Stochastic Oscillator
- SFST 76.70
- GNFT 94.23
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.